Get the Stockscreener App
58.38
1.53%
0.88
After Hours:
58.38
Bruker Corp stock is traded at $58.38, with a volume of 1.40M.
It is up +1.53% in the last 24 hours and up +0.83% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
See More
Previous Close:
$57.50
Open:
$57.56
24h Volume:
1.40M
Relative Volume:
1.06
Market Cap:
$8.81B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
26.90
EPS:
2.17
Net Cash Flow:
$156.70M
1W Performance:
+9.39%
1M Performance:
+0.83%
6M Performance:
-24.43%
1Y Performance:
-9.63%
1-Day Range:
$57.56
$59.00
1-Week Range:
$52.59
$59.51
52-Week Range:
$48.07
$94.86
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
58.38 | 8.81B | 3.24B | 304.90M | 156.70M | 2.17 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
FY2024 Earnings Estimate for Bruker Issued By Zacks Research - MarketBeat
Bruker (STU:BKD) Enterprise Value : €10,687 Mil (As of Nov. 26, 2024) - GuruFocus.com
Bruker Co. (NASDAQ:BRKR) Shares Acquired by Natixis Advisors LLC - MarketBeat
Bruker Q4 Profit DownUpdate - RTTNews
Hedge Funds Pitch Short, Activist and Long Bets at Sohn London - BNN Bloomberg
Bruker CEO Frank Laukien buys $5 million in company stock By Investing.com - Investing.com Canada
Bruker CEO Frank Laukien buys $5 million in company stock - Investing.com
Bruker Announces Quarterly Dividend - Yahoo Finance
T. Rowe Price Investment Management Reduces Stake in Bruker Corp - GuruFocus.com
Bruker stock touches 52-week low at $54.55 amid market shifts - Investing.com
IR Spectroscopy Market to surpass USD 2 billion by 2032, Says Global Market Insights inc. - GlobeNewswire Inc.
Bruker's (NASDAQ:BRKR) Problems Go Beyond Weak Profit - Yahoo Finance
Polar Capital Holdings Plc Increases Stake in Bruker Corp - GuruFocus.com
FMR LLC Bolsters Stake in Bruker Corp - GuruFocus.com
Dragonfly Energy, Bruker Partner To Accelerate Battery Tech Development - RV PRO
Dragonfly Energy, Bruker Partner to Boost Battery Technology - RV Business
Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development - 新浪香港
Leerink Partnrs Issues Negative Outlook for Bruker Earnings - MarketBeat
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform - Marketscreener.com
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform – Company AnnouncementFT.com - Financial Times
Kornitzer Capital Management Inc. KS Buys New Position in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker Co. (NASDAQ:BRKR) Receives $79.36 Consensus Price Target from Brokerages - MarketBeat
Bruker Corporation (NASDAQ:BRKR) Q3 2024 Earnings Call Transcript - Insider Monkey
FY2024 EPS Estimates for Bruker Reduced by Leerink Partnrs - MarketBeat
Bruker stock price target cut, hold rating sustained on Q3 performance - Investing.com
Bruker Analysts Cut Their Forecasts After Q3 Results - MSN
Earnings call: Bruker adjusts guidance amid biopharma, China challenges - Investing.com
Decoding 3 Analyst Evaluations For Bruker - Benzinga
Bruker (NASDAQ:BRKR) Price Target Cut to $69.00 by Analysts at Barclays - MarketBeat
Bruker Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Sur - GuruFocus.com
Bruker Corp (BRKR) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Pressures - Yahoo Finance
JPMorgan cuts Bruker target to $80, maintains overweight - Investing.com
Bruker: Q3 Earnings Snapshot - The Washington Post
Bruker stock touches 52-week low at $54.74 amid market shifts - Investing.com
Bruker (NASDAQ:BRKR) Hits New 12-Month LowHere's Why - MarketBeat
Bruker (BRKR) Q3 Earnings and Revenues Lag Estimates - MSN
Bruker earnings matched, revenue fell short of estimates - Investing.com
Bruker falls after lowering FY profit forecast - XM
Bruker Corp Q3 2024 Earnings: Revenue Surpasses Estimates at $86 - GuruFocus.com
Bruker Reports Third Quarter 2024 Financial Results - Yahoo Finance
A Look Ahead: Bruker's Earnings Forecast - Benzinga
PineStone Asset Management Inc. Purchases 26,700 Shares of Bruker Co. (NASDAQ:BRKR) - MarketBeat
What Is Bruker Corporation's (NASDAQ:BRKR) Share Price Doing? - Yahoo Finance
Bruker (BRKR) Set to Announce Earnings on Tuesday - MarketBeat
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Assenagon Asset Management S.A. Cuts Position in Bruker Co. (NASDAQ:BRKR) - MarketBeat
Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast - Yahoo Finance
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics – Company AnnouncementFT.com - Financial Times
Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics - Yahoo Finance
BRKR Stock to Gain From Newly Formed Bruker Spatial Biology Division - MSN
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bruker Corp Stock (BRKR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| LAUKIEN FRANK H | PRESIDENT & CEO |
Nov 18 '24 |
Buy |
50.14 |
100,000 |
5,014,069 |
38,439,563 |
| ROSENTHAL BOB | Director |
Aug 15 '24 |
Option Exercise |
23.37 |
12,500 |
292,075 |
35,647 |
| ROSENTHAL BOB | Director |
Aug 15 '24 |
Sale |
63.14 |
4,684 |
295,748 |
30,963 |
0.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):